Mirmiran M, Scholtens J, van de Poll N E, Uylings H B, van der Gugten J, Boer G J
Brain Res. 1983 Apr;283(2-3):277-86. doi: 10.1016/0165-3806(83)90184-0.
In order to test the hypothesis that active sleep (AS) is important for the normal development of the central nervous system, 3 different deprivation methods were applied to male Wistar rat pups during the first month of life. Daily injection of clomipramine from 8 to 21 days of age reduced the high level of AS to less than the adult value throughout most of the experimental period. Administration of clonidine from 8 to 21 days of life induced an almost total suppression of AS. Instrumental deprivation, using the 'pendulum' method, led to a significant (but less severe) AS reduction during 2-4 weeks of postnatal age. Open-field behavior testing in adulthood revealed a higher than normal level of ambulation in all 3 experimental groups. Masculine sexual responses were deficient, due to a low level of both mounts and ejaculations, in both clomipramine- and clonidine-treated animals. Neither passive avoidance learning nor dark preference tests revealed any differences between the experimental and control rats. Sleep observations showed that there was an abnormally high incidence of large myoclonic jerks during AS in both clomipramine- and clonidine-treated rats. Subsequent measurement of regional brain weights showed a significant reduction in the cerebral cortex and medulla oblongata, as compared with the respective control groups, in both the clomipramine- and the clonidine-treated rats. In addition, DNA and protein determination in the affected brain areas showed a proportional reduction in the cortex and in the medulla. These results demonstrate that interference with normal functioning either of AS per se or of specific monoaminergic transmitter systems during early development can produce long-lasting behavioral as well as brain morphological and biochemical abnormalities in later life.
为了验证主动睡眠(AS)对中枢神经系统正常发育至关重要这一假说,在雄性Wistar大鼠幼崽出生后的第一个月采用了3种不同的剥夺方法。从8日龄至21日龄每日注射氯米帕明,在实验期的大部分时间内,可将高水平的主动睡眠降低至低于成年值。从8日龄至21日龄给予可乐定,可导致主动睡眠几乎完全被抑制。采用“摆动”法进行器械剥夺,在出生后2 - 4周可导致主动睡眠显著减少(但程度较轻)。成年后的旷场行为测试显示,所有3个实验组的行走水平均高于正常。在氯米帕明和可乐定处理的动物中,由于爬跨和射精水平较低,雄性性行为反应存在缺陷。被动回避学习测试和暗偏好测试均未显示实验大鼠与对照大鼠之间存在任何差异。睡眠观察表明,氯米帕明和可乐定处理的大鼠在主动睡眠期间大肌阵挛性抽搐的发生率异常高。随后对脑区重量的测量显示,与各自的对照组相比,氯米帕明和可乐定处理的大鼠大脑皮层和延髓重量均显著降低。此外,对受影响脑区的DNA和蛋白质测定表明,皮层和延髓中的含量呈比例减少。这些结果表明,在早期发育过程中,干扰主动睡眠本身或特定单胺能递质系统的正常功能,可在以后的生活中产生持久的行为以及脑形态和生化异常。